Dovonex and Taltz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dovonex (calcipotriene) and Taltz (ixekizumab). Common drug interactions include angioedema among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Dovonex and Taltz. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Dovonex?

Dovonex has active ingredients of calcipotriene. It is often used in psoriasis. eHealthMe is studying from 3,035 Dovonex users. Check the latest studies of Dovonex.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,778 Taltz users. Check the latest studies of Taltz.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

31 people who take Dovonex and Taltz together, and have interactions are studied.

Dovonex and Taltz drug interactions.

What are the common drug interactions of Dovonex and Taltz, by gender? *:

female:

  1. Angioedema (rapid swelling of the dermis)
  2. Ear infection
  3. Pain in extremity
  4. Eye pruritus (eye itching)
  5. Joint swelling
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  8. Cough
  9. Arthralgia (joint pain)
  10. Back pain

male:

  1. Arthralgia (joint pain)
  2. Fibrous histiocytoma (non cancer fibrous skin lesion)
  3. Injection site haemorrhage (bleeding from injection site)
  4. Injection site pain
  5. Adenoid cystic carcinoma (cancer that can exist in many different body sites)
  6. Malignant neoplasm of lacrimal gland (cancer tumour of tear gland of eye)
  7. Lentigo (a small pigmented spot on the skin with a clearly-defined edge, surrounded by normal-appearing skin)
  8. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
  9. Poikiloderma (pigmentary and atrophic changes in the skin)
  10. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

What are the common drug interactions of Dovonex and Taltz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Headache (pain in head)
  2. Injection site haemorrhage (bleeding from injection site)
  3. Intestinal polyp (small growths in the bowel with the potential for further growth)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Pain of skin
  6. Pruritus (severe itching of the skin)
  7. Sinusitis (inflammation of sinus)
  8. Arthralgia (joint pain)
  9. Anxiety
  10. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Joint swelling
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  3. Pain in extremity
  4. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  5. Back pain
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  9. Cellulitis (infection under the skin)
  10. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)

60+:

  1. Rash
  2. Anorectal discomfort
  3. Burning sensation
  4. Injection site pain
  5. Injection site swelling
  6. Pain
  7. Vulvovaginal burning sensation

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 25.81%
  2. High Blood Pressure: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Dovonex and Taltz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dovonex and Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dovonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dovonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taltz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcipotriene and ixekizumab (the active ingredients of Dovonex and Taltz, respectively), and Dovonex and Taltz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: